A carregar...
Antiangiogenic Agents in First-Line and Second-Line Therapy for Advanced Colorectal Cancer
In the past 10 years, tremendous headway has been made in the fight against colorectal cancer. Advances have included the approval of new cytotoxic agents (oxaliplatin, irinotecan, and capecitabine), as well as biologic agents (cetuximab, bevacizumab, and panitumumab). Studies of bevacizumab, an ant...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
International Society of Gastrointestinal Oncology
2007
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2666834/ https://ncbi.nlm.nih.gov/pubmed/19365574 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|